Filing Details

Accession Number:
0001161697-23-000243
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-07 17:00:21
Reporting Period:
2023-04-05
Accepted Time:
2023-04-07 17:00:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292636 S David Tierney 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2023-04-05 30,000 $0.79 343,541 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2023-04-05 30,000 $16.83 313,541 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2023-04-05 30,000 $0.00 30,000 $0.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
280,500 2023-06-15 No 4 M Direct
Footnotes
  1. Dr. Tierney has advised the Company that the sale of shares was to pay the exercise price of the shares and to raise funds for personal reasons, and does not relate to any disagreements between Dr. Tierney and the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
  2. Shares were sold in various lots from $16.70 to $16.98 per share. The listed sales price represents a weighted average price for the shares sold.
  3. The option was granted on June 15, 2016 and previously vested in two annual installments.